NCT05942807Recruiting
Observational Monocentric Study on Biliary Tract Cancer (BABEL)
The Prognostic and Predictive Role of Clinical, Biochemical, Pathological and Molecular Characteristics of Patients With Biliary Tract Cancer: an Observational Monocentric Study. (BABEL)
Source: ClinicalTrials.gov · Last updated 26 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
BABEL is an observational, single-center, prospective study about patients affected by biliary tract cancers (BTC) treated at the Medical Oncology Unit of the FPUAG - IRCCS.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 560 (estimated)
- First submitted
- 20 Mar 2023
- Start date
- 15 May 2021
- Primary completion date
- 15 May 2025
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT05942807
What you commit to
- Study type: Observational
- Planned participants: 560
- From 15 May 2021 to the primary completion date, 15 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients without available clinical data;
- Patients without histological diagnosis of BTC;
- Patients without written informed consent.
Who the study is looking for
- Patients with biliary tract cancer;
- Patients with radiological evident disease;
- Patients \>18 anni;
- Written informed consent;
- Patients with at least one oncological visit.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli/IRCSS - UOC di Oncologia Medica Coordinator of this site? Confirm its status | Roma | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.